financetom
Market
financetom
/
Market
/
$3.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
$3.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
May 20, 2024 5:54 AM

The Dow Jones index closed above the $40,000 mark on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

Tecogen

The Trade: Tecogen Inc. ( TGEN ) Director John Hatsopoulos bought a total of 3,000 shares at an average price of $0.75. To acquire these shares, it cost around $2,248.

What's Happening: On May 8, Tecogen ( TGEN ) reported revenues of $6.2 million and net loss of $1.1 million for the quarter ended March 31.

What Tecogen Does: Tecogen Inc ( TGEN ), designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services, and Energy Production.

Standard BioTools

The Trade: Standard BioTools Inc. ( LAB ) Director Casdin Partners FO1-MSV, LP acquired a total of 1,352,072 shares at an average price of $2.56. To acquire these shares, it cost around $3.46 million.

What's Happening: On May 8, Standard BioTools ( LAB ) posted downbeat quarterly sales.

What Standard BioTools Does: Standard BioTools Inc ( LAB ) develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster.

OPKO Health

The Trade: OPKO Health, Inc. ( OPK ) 10% owner Frost Gamma Investments Trust acquired a total of 163,997 shares at an average price of $1.29. The insider spent around $211,195 to buy those shares.

What's Happening: On May 7, OPKO Health ( OPK ) reported worse-than-expected first-quarter financial results.

What OPKO Health Does: OPKO Health Inc ( OPK ) is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko’s diagnostics business includes a core genetic testing operation.

Check This Out: Zoom Video, Wix.com And 3 Stocks To Watch Heading Into Monday

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved